171 related articles for article (PubMed ID: 10417270)
21. Gene therapy: X-SCID transgene leukaemogenicity.
Thrasher AJ; Gaspar HB; Baum C; Modlich U; Schambach A; Candotti F; Otsu M; Sorrentino B; Scobie L; Cameron E; Blyth K; Neil J; Abina SH; Cavazzana-Calvo M; Fischer A
Nature; 2006 Sep; 443(7109):E5-6; discussion E6-7. PubMed ID: 16988659
[TBL] [Abstract][Full Text] [Related]
22. IL2RGbase: a database of gamma c-chain defects causing human X-SCID.
Puck JM
Immunol Today; 1996 Nov; 17(11):507-11. PubMed ID: 8961626
[No Abstract] [Full Text] [Related]
23. [The signal transduction mechanism of IL-4 in X-linked severe combined immunodeficiency patients].
Izuhara K
Rinsho Ketsueki; 1997 Mar; 38(3):186-8. PubMed ID: 9095654
[No Abstract] [Full Text] [Related]
24. Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency.
Tassara C; Pepper AE; Puck JM
Hum Mol Genet; 1995 Sep; 4(9):1693-5. PubMed ID: 8541866
[No Abstract] [Full Text] [Related]
25. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
Leonard WJ
Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
[TBL] [Abstract][Full Text] [Related]
26. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
Russell SM; Johnston JA; Noguchi M; Kawamura M; Bacon CM; Friedmann M; Berg M; McVicar DW; Witthuhn BA; Silvennoinen O
Science; 1994 Nov; 266(5187):1042-5. PubMed ID: 7973658
[TBL] [Abstract][Full Text] [Related]
27. Immune deficiencies due to defects in cytokine signaling.
Kelly J; Leonard WJ
Curr Allergy Asthma Rep; 2003 Sep; 3(5):396-401. PubMed ID: 12906775
[TBL] [Abstract][Full Text] [Related]
28. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
McCormack MP; Rabbitts TH
N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
[No Abstract] [Full Text] [Related]
29. [Primary immunodeficiency syndrome as gene experiment of nature].
Yata J
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):133-7. PubMed ID: 7553046
[No Abstract] [Full Text] [Related]
30. Three novel mutations in the interleukin-2 receptor gamma chain gene in four Japanese patients with X-linked severe combined immunodeficiency.
Minegishi Y; Ishii N; Maeda H; Takagi S; Tsuchida M; Okawa H; Sugamura K; Yata J
Hum Genet; 1995 Dec; 96(6):681-3. PubMed ID: 8522327
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the interleukin-2 receptor gamma gene as the cause of lymphopenia in a neonate vertically exposed to human immunodeficiency virus.
Neubert J; Meindl A; Theisen A; Adams O; Schulz A; Feyen O; Niehues T
Pediatr Infect Dis J; 2005 Feb; 24(2):187-9. PubMed ID: 15702055
[TBL] [Abstract][Full Text] [Related]
32. Signaling normal human T-cells: synergism between CD2 antigen and CD3/T cell receptor alpha beta complex in the elicitation of IL-2 and IL-2 receptor gene expression.
Li B; Sehajpal P; Estin D; Fotino M; Suthanthiran M
Transplant Proc; 1991 Feb; 23(1 Pt 1):77-8. PubMed ID: 1671306
[No Abstract] [Full Text] [Related]
33. Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: mutation detection methods and utilization.
Puck JM; Middelton L; Pepper AE
Hum Genet; 1997 May; 99(5):628-33. PubMed ID: 9150730
[TBL] [Abstract][Full Text] [Related]
34. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2.
Smith KA
Curr Opin Immunol; 1992 Jun; 4(3):271-6. PubMed ID: 1418705
[TBL] [Abstract][Full Text] [Related]
36. The interleukin 2 receptor.
Smith KA
Annu Rev Cell Biol; 1989; 5():397-425. PubMed ID: 2688708
[No Abstract] [Full Text] [Related]
37. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2, autotolerance, and autoimmunity.
Kroemer G; Andreu JL; Gonzalo JA; Gutierrez-Ramos JC; Martínez C
Adv Immunol; 1991; 50():147-235. PubMed ID: 1950796
[No Abstract] [Full Text] [Related]
40. Erythropoietin receptor mutations and Olympic glory.
Longmore GD
Nat Genet; 1993 Jun; 4(2):108-10. PubMed ID: 8348144
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
